Citation Impact
Citing Papers
Cluster failure: Why fMRI inferences for spatial extent have inflated false-positive rates
2016 Standout
TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis
2008 StandoutScience
A "Silent" Polymorphism in the MDR 1 Gene Changes Substrate Specificity
2006 StandoutScience
The clinical symptoms of Parkinson's disease
2016 Standout
DJ-1, a novel regulator of the tumor suppressor PTEN
2005
Clinical and pathological features of a Parkinsonian syndrome in a family with an Ala53Thr alpha-synuclein mutation.
2001
The Role of Innate and Adaptive Immunity in Parkinson's Disease
2013
Proteasome dysfunction in aged human α-synuclein transgenic mice
2006
Estimating the reproducibility of psychological science
2015 StandoutScience
Characterization of pathogenic SORL1 genetic variants for association with Alzheimer’s disease: a clinical interpretation strategy
2017
Cochrane Database of Systematic Reviews
2003 Standout
The role of FUS gene variants in neurodegenerative diseases
2014
The Role of Autophagy in Parkinson's Disease
2012
A polymorphic variation of serine to tyrosine at codon 18 in the ubiquitin C-terminal hydrolase-L1 gene is associated with a reduced risk of sporadic Parkinson's disease in a Japanese population
2001
Patient-centered integrated healthcare improves quality of life in Parkinson’s disease patients: a randomized controlled trial
2018
Epidemiologic studies of environmental exposures in Parkinson's disease
2007
Restless Legs Syndrome
2008
Parkinson's disease
2021 Standout
The Ubiquitin Proteasome System in Neurodegenerative Diseases
2003 StandoutNobel
Update in the epidemiology of Parkinson's disease
2008
Rewiring of the Fruit Metabolome in Tomato Breeding
2018 Standout
Mechanisms Underlying Inflammation in Neurodegeneration
2010 Standout
CD22 blockade restores homeostatic microglial phagocytosis in ageing brains
2019 StandoutNatureNobel
Expression of the Ciona intestinalis Alternative Oxidase (AOX) in Drosophila Complements Defects in Mitochondrial Oxidative Phosphorylation
2009
Risk of Obstructive Sleep Apnea in Parkinson’s Disease: A Meta-Analysis
2013
Molecular pathogenesis of Parkinson disease: insights from genetic studies
2009
The Arabidopsis Information Resource (TAIR): improved gene annotation and new tools
2011 Standout
FUS(1-359) transgenic mice as a model of ALS: pathophysiological and molecular aspects of the proteinopathy
2018
Good practice in the management of amyotrophic lateral sclerosis: Clinical guidelines. An evidence‐based review with good practice points. EALSC Working Group
2007
Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency
2009 Standout
Phaeochromocytoma
2005 Standout
Mitochondrial DNA haplogroup cluster UKJT reduces the risk of PD
2005
Guillain–Barré Syndrome
2012 Standout
Epidemiology of Parkinson's disease
2006 Standout
Amyotrophic lateral sclerosis
2011 Standout
A Broken α-Helix in Folded α-Synuclein
2003 StandoutNobel
Deciphering the role of heterozygous mutations in genes associated with parkinsonism
2007
Part II: α-synuclein and its molecular pathophysiological role in neurodegenerative disease
2003
Integrating single-cell transcriptomic data across different conditions, technologies, and species
2018 Standout
Parkinson's disease
2009 Standout
The value of Arabidopsis research in understanding human disease states
2010
Culture and the categorization of emotions.
1991
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Mitochondria: In Sickness and in Health
2012 Standout
Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease
2016 Standout
Epidemiology and etiology of Parkinson’s disease: a review of the evidence
2011
Alzheimer's Disease and Parkinson's Disease
2003
Comprehensive literature review and statistical considerations for microarray meta-analysis
2012
Caffeine Intake, Smoking, and Risk of Parkinson Disease in Men and Women
2012
Parkinson's disease in the Western Pacific Region
2019
PINK, PANK, or PARK? A clinicians' guide to familial parkinsonism
2004
Machado-Joseph Disease: from first descriptions to new perspectives
2011
Parkinson's disease
2015 Standout
Autophagy in Human Health and Disease
2013 Standout
Power failure: why small sample size undermines the reliability of neuroscience
2013 Standout
Caffeine and risk of Parkinson's disease in a large cohort of men and women
2012
From endoplasmic-reticulum stress to the inflammatory response
2008 StandoutNature
Parkinson's disease and α‐synuclein expression
2011
Distinct Clinical Features of Paraganglioma Syndromes Associated With <EMPH TYPE="ITAL">SDHB</EMPH> and <EMPH TYPE="ITAL">SDHD</EMPH> Gene Mutations
2004
The epidemiology of Parkinson's disease: risk factors and prevention
2016 Standout
Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases
2006 StandoutNature
Alpha-synuclein and neurodegenerative diseases
2001
A Liquid-to-Solid Phase Transition of the ALS Protein FUS Accelerated by Disease Mutation
2015 Standout
Neuroinflammatory mechanisms in Parkinson's disease: Potential environmental triggers, pathways, and targets for early therapeutic intervention
2007
Sleep disorders and daytime sleepiness in Parkinson’s disease
2009
Parkinson's disease research in a prospective cohort in China
2015
α-synuclein locus duplication as a cause of familial Parkinson's disease
2004 Standout
Decreased platelet glutamate uptake and genetic risk factors in patients with Parkinson's disease
2001
EFNS task force on management of amyotrophic lateral sclerosis: guidelines for diagnosing and clinical care of patients and relatives
2005
Relationship of Apolipoprotein E and Age at Onset to Parkinson Disease Neuropathology
2006
Coffee, ADORA2A, and CYP1A2: the caffeine connection in Parkinson’s disease
2011
alpha-synuclein gene haplotypes are associated with Parkinson's disease
2001
Huntington's Disease and Related Disorders
2005
A common LRRK2 mutation in idiopathic Parkinson's disease
2005 Standout
Genetics of Parkinson's Disease
2012
Parkinson's Disease Patient-Derived Induced Pluripotent Stem Cells Free of Viral Reprogramming Factors
2009 Standout
No association of chromatin-modifying protein 2B with sporadic frontotemporal dementia
2006
Family Violence and Football: The Effect of Unexpected Emotional Cues on Violent Behavior*
2011 StandoutNobel
Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors
2008 Standout
Neuroinflammation in Parkinson's disease: Its role in neuronal death and implications for therapeutic intervention
2009
Monogenic Parkinson's disease and parkinsonism: Clinical phenotypes and frequencies of known mutations
2013
Epidemiology of Alzheimer's disease and other forms of dementia in China, 1990–2010: a systematic review and analysis
2013 Standout
Colonic inflammation in Parkinson's disease
2012
Characterization of PINK1 processing, stability, and subcellular localization
2008
A molecular pathway of neurodegeneration linking α-synuclein to ApoE and Aβ peptides
2008 StandoutNobel
TMEM41B Is a Pan-flavivirus Host Factor
2020 StandoutNobel
Association of Single-Nucleotide Polymorphisms of the Tau Gene With Late-Onset Parkinson Disease
2001
Molecular Mechanisms of Amyloidosis
2003 Standout
Impaired recognition of emotion in facial expressions following bilateral damage to the human amygdala
1994 StandoutNature
Parkinson's Disease
2003 Standout
Succinate Dehydrogenase Supports Metabolic Repurposing of Mitochondria to Drive Inflammatory Macrophages
2016 Standout
CADD: predicting the deleteriousness of variants throughout the human genome
2018 Standout
Caffeine for treatment of Parkinson disease
2012
The genetics of P arkinson's disease: Progress and therapeutic implications
2013
APOE-ε2 allele associated with higher prevalence of sporadic Parkinson disease
2004
Dopamine Dysregulation Syndrome
2009
Clinical and pathological features of a parkinsonian syndrome in a family with an Ala53Thr α‐synuclein mutation
2001
Dietary fat intake and risk for Parkinson's disease
2014
Salivary gland application of botulinum toxin for the treatment of sialorrhea.
2007
What Genetics Tells us About the Causes and Mechanisms of Parkinson's Disease
2011
Multidrug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C>T affects mRNA stability
2005
Copper Homeostasis and Neurodegenerative Disorders (Alzheimer's, Prion, and Parkinson's Diseases and Amyotrophic Lateral Sclerosis)
2006 Standout
The effects of feedback interventions on performance: A historical review, a meta-analysis, and a preliminary feedback intervention theory.
1996 Standout
Engineering the alternative oxidase gene to better understand and counteract mitochondrial defects: state of the art and perspectives
2014
Small molecule probes to quantify the functional fraction of a specific protein in a cell with minimal folding equilibrium shifts
2014 StandoutNobel
Update on Parkinson Disease
2003
Self-Regulation Failure: An Overview
1996
Integrating Heterogeneous High-Throughput Data for Meta-Dimensional Pharmacogenomics and Disease-Related Studies
2012
MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis
2018 Standout
Alcohol intake and risk of Parkinson's disease: A meta‐analysis of observational studies
2014
Genotype-phenotype correlations between GBA mutations and Parkinson disease risk and onset
2008
Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease
2007
The Multifaceted Roles of Autophagy in Flavivirus-Host Interactions
2018
Flt3L controls the development of radiosensitive dendritic cells in the meninges and choroid plexus of the steady-state mouse brain
2011 StandoutNobel
Evaluating replicability of laboratory experiments in economics
2016 StandoutScience
Organoselenium and Organotellurium Compounds: Toxicology and Pharmacology
2004 Standout
Dietary folate, vitamin B 12 , and vitamin B 6 and the risk of Parkinson disease
2006
Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress
2005
A Guillain-Barré syndrome variant with prominent facial diplegia
2009
Works of Eng‐King Tan being referenced
Exploring an interaction of adenosine A2A receptor variability with coffee and tea intake in Parkinson's disease
2006
In search of the true amok: amok as viewed with the Malay culture
1976
Fragile X premutation alleles in SCA, ET, and parkinsonism in an Asian cohort
2004
Analysis of LRRK2 G2019S and I2020T mutations in Parkinson's disease
2005
Alpha synuclein promoter and risk of Parkinson's disease: microsatellite and allelic size variability
2002
SORL1 haplotypes modulate risk of Alzheimer's disease in Chinese
2007
Genetic analysis of SCA2, 3 and 17 in idiopathic Parkinson's disease
2006
Dose-dependent protective effect of coffee, tea, and smoking in Parkinson's disease: a study in ethnic Chinese
2003
Comprehensive evaluation of common genetic variation within LRRK2 reveals evidence for association with sporadic Parkinson's disease
2005
Non-synonymous GIGYF2 variants in Parkinson’s disease from two Asian populations
2009
LRRK2 R1628P increases risk of Parkinson’s disease: replication evidence
2008
Superoxide drives progression of Parkin/PINK1-dependent mitophagy following translocation of Parkin to mitochondria
2017
Restless legs syndrome in an Asian population: A study in Singapore
2001
The G2019S LRRK2 mutation is uncommon in an Asian cohort of Parkinson's disease patients
2005
Functional COMT variant predicts response to high dose pyridoxine in Parkinson's disease
2005
Association between caffeine intake and risk of Parkinson's disease among fast and slow metabolizers
2007
Differential Effects of Black versus Green Tea on Risk of Parkinson's Disease in the Singapore Chinese Health Study
2007
Dopamine D2 receptor TaqIA and TaqIB polymorphisms in Parkinson's disease
2003
CARD15 variants in patients with sporadic Parkinson's disease
2006
Genetic Testing in Spinocerebellar Ataxias
2001
Functional parkin promoter polymorphism in Parkinson's disease: New data and meta-analysis
2010
The LRRK2 Gly2385Arg variant is associated with Parkinson’s disease: genetic and functional evidence
2006
Spinocerebellar ataxia type 3 presenting as an l-DOPA responsive dystonia phenotype in a Chinese family
2003
Botulinum toxin treatment of sialorrhea: comparing different therapeutic preparations
2006
Case Control Polysomnographic Studies of Sleep Disorders in Parkinson's Disease
2011
Pathogenic mutations in Parkinson disease
2007
Dietary cholesterol, fats and risk of Parkinson's disease in the Singapore Chinese Health Study
2015
LRRK2 in Parkinson’s disease: genetic and clinical studies from patients
2009
Genetic analysis of DJ-1 in a cohort Parkinson’s disease patients of different ethnicity
2004
Utility of lymphoblastoid cell lines
2009
Restless legs syndrome in Parkinson's disease
2002
Analysis of MDR1 haplotypes in Parkinson's disease in a white population
2004
Recurrent jaw dislocation after botulinum toxin treatment for sialorrhoea in amyotrophic lateral sclerosis
2001
Case–control study of restless legs syndrome and quality of sleep in Parkinson's disease
2007
Effect of MDR1 Haplotype on Risk of Parkinson Disease
2005
Analysis of Lingo1 variant in sporadic and familial essential tremor among Asians
2010
Variability and validity of polymorphism association studies in Parkinson’s disease
2000
The impact of non‐motor symptoms on the quality of life of Parkinson's disease patients: a longitudinal study
2016
Resveratrol alleviates MPTP‐induced motor impairments and pathological changes by autophagic degradation of α‐synuclein via SIRT1‐deacetylated LC3
2016
Polymorphism of NACP-Rep1 in Parkinson’s disease: An etiologic link with essential tremor?
2000
Identification of a novel risk variant in the FUS gene in essential tremor
2013
Association of LRRK2 Haplotype With Age at Onset in Parkinson Disease
2017
Analysis of GWAS-linked loci in Parkinson disease reaffirms PARK16 as a susceptibility locus
2010
Facial diplegia: cranial variant of Guillain-Barré syndrome?
1999
LINGO-1 and Neurodegeneration: Pathophysiologic Clues for Essential Tremor?
2011
Analysis of LRRK2 functional domains in nondominant Parkinson disease
2005
Alpha-synuclein haplotypes implicated in risk of Parkinson’s disease
2004